SpectralMD has been awarded a $149m contract by the US Biomedical Advanced Research and Development Authority (BARDA).
The contract supports SpectralMD’s DeepView System, an artificial intelligence tool to assess the severity and the healing of a wound, typically a burn or diabetic foot ulcer.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?